Perrigo Ordinary Shares reported $3.55B in Debt for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Aphria Inc APH:CN C$ 928.67M 381.15M
Bayer BAYN:GR € 41766M 1394M
Bristol Myers Squibb BMY:US $ 44742M 416M
Catalent CTLT:US $ 4304M 1063M
Coherus Biosciences CHRS:US $ 407.17M 1.09M
Corcept Therapeutics CORT:US $ 0M 0M
Eli Lilly And LLY:US $ 17085.4M 570.3M
Endo International Ordinary Shares ENDP:US $ 8300.6M 3.52M
Flexion Therapeutics FLXN:US $ 250.5M 28.96M
Gw Pharmaceuticals GWPH:US $ 15.19M 0.11M
Horizon Pharma HZNP:US $ 2573.86M 2.58M
JAZZ PHA JAZZ:US $ 6285.05M 459.25M
Lannett LCI:US $ 596.98M 6.29M
Pacira Pharmaceuticals PCRX:US $ 481.9M 6.51M
Perrigo Ordinary Shares PRGO:US $ 3550.3M 5.6M
Phibro Animal Health PAHC:US $ 405.26M 13.18M
Prestige Brands PBH:US $ 1607.1M 52.98M
Supernus Pharmaceuticals SUPN:US $ 374.79M 4.4M
Teva Pharmaceutical TEVA:IT 23.75B 1.39B
Xeris Pharmaceuticals Inc XERS:US $ 87.71M 235K
Zoetis ZTS:US $ 6592M 604M